Dermatology Doctors in Bridgeville, PA Accepting Medicare

2 Dermatology doctors found. Showing 1 - 2

Katie Lynn O'brien, PA-C Dermatology Medicare: Not Enrolled in Medicare Practice Location: 160 Millers Run Rd Ste 500, Bridgeville, PA 15017 Phone: 412-564-5444    Fax: 412-564-5478

Dr. Jason George Whalen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 160 Millers Run Rd Ste 500, Bridgeville, PA 15017 Phone: 412-564-5444    Fax: 412-564-5478

News Archive

Gilead submits cobicistat NDA with FDA for treatment of HIV

Gilead Sciences, Inc. announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain commercially available protease inhibitors, including atazanavir and darunavir, in order to enable once-daily dosing.

PharMerica to purchase $25 million of common stock

PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today announced that its Board of Directors has authorized an increase in its existing share purchase program that will allow the Company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.

Study: Regardless of pain, women are more likely to be prescribed pain-relieving drugs

Regardless of pain, social class or age, a woman is more likely to be prescribed pain-relieving drugs. A study published in Gaceta Sanitaria (Spanish health scientific journal) affirms that this phenomenon is influenced by socioeconomic inequality between genders in the Autonomous Community in which the patient resides.

AstraZeneca submits sNDA for SYMBICORT in chronic obstructive pulmonary disease

AstraZeneca today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for approval of a new indication for SYMBICORT (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of patients with Chronic Obstructive Pulmonary Disease (COPD). SYMBICORT is currently approved for the long-term maintenance treatment of asthma in patients 12 years and older.

Advanced Liquid Logic awarded an NIAID contract to develop a rapid HIV diagnostic device

Advanced Liquid Logic announced today that it has received a large, four-year contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for the development of a rapid, point-of-care, diagnostic device for the detection of HIV in low resource settings.

Read more Medical News

› Verified 9 days ago